TRICIDA, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2018-11-20: Study NCT03710291; Company role Lead sponsor; Phase Phase 3; Status Terminated.
- 2017-12-20: Study NCT03390842; Company role Lead sponsor; Phase Phase 3; Status Completed.
- 2017-09-26: Study NCT03317444; Company role Lead sponsor; Phase Phase 3; Status Completed.
- 2016-03: Study NCT02809183; Company role Lead sponsor; Phase Phase 1, Phase 2; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2018-11-20 | NCT03710291 Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis | Lead sponsor | Phase 3 | Terminated | Metabolic Acidosis; Chronic Kidney Disease | 1,480 | 2022-09-27 |
| 2017-12-20 | NCT03390842 Long-term Safety Extension to Study TRCA-301 | Lead sponsor | Phase 3 | Completed Results posted | Metabolic Acidosis | 196 | 2019-02-22 |
| 2017-09-26 | NCT03317444 Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease | Lead sponsor | Phase 3 | Completed Results posted | Metabolic Acidosis | 217 | 2018-05-15 |
| 2016-03 | NCT02809183 Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis | Lead sponsor | Phase 1, Phase 2 | Completed Results posted | Acidosis | 135 | 2016-11 |